Published in Front Neurol on February 16, 2017
Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology (1999) 6.03
Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98
Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA (2002) 4.38
Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med (2013) 4.35
Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol (2012) 3.98
Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ (2011) 3.74
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord (2009) 3.56
Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep (2006) 3.12
Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology (1992) 3.08
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol (2007) 2.99
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain (2000) 2.76
Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry (2003) 2.59
Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep (2009) 2.59
Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study. Mov Disord (2006) 2.47
Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc (2000) 2.38
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord (2010) 2.34
Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med (2009) 2.09
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord (2011) 2.05
Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology (2012) 1.91
Parkinson's disease and sleepiness: an integral part of PD. Neurology (2002) 1.85
Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord (2000) 1.78
The nighttime problems of Parkinson's disease. Clin Neuropharmacol (1988) 1.77
REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry (2008) 1.76
A timeline for Parkinson's disease. Parkinsonism Relat Disord (2009) 1.75
Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology (2003) 1.73
Autonomic dysfunction in Parkinson's disease. Neurol Sci (2003) 1.69
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord (2003) 1.69
Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. J Neurol (2007) 1.65
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol (2010) 1.63
Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med (2010) 1.62
Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med (2011) 1.57
Are periodic leg movements associated with clinical sleep disturbance? Sleep (1996) 1.57
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry (2012) 1.54
Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain (2009) 1.53
Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol (2014) 1.50
Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2010) 1.50
Adult chronic sleepwalking and its treatment based on polysomnography. Brain (2005) 1.49
A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry (1989) 1.47
Urinary incontinence following deep brain stimulation of the pedunculopontine nucleus. Acta Neurochir (Wien) (2011) 1.46
Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. Sleep Med Rev (2006) 1.44
Serotonergic antidepressants are associated with REM sleep without atonia. Sleep (2004) 1.42
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry (2005) 1.42
Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep (1992) 1.41
Parkinson's disease sleep scale--validation of the revised version PDSS-2. Mov Disord (2011) 1.41
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med (2003) 1.39
Symposium: Normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res (1993) 1.35
Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep (2000) 1.30
Case control polysomnographic studies of sleep disorders in Parkinson's disease. PLoS One (2011) 1.30
Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord (2003) 1.29
Approved and investigational uses of modafinil : an evidence-based review. Drugs (2008) 1.28
Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir Med (2003) 1.27
Falling asleep whilst driving: are drivers aware of prior sleepiness? Int J Legal Med (1998) 1.27
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med (2016) 1.21
A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep (1997) 1.21
The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol (2002) 1.19
Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep (2002) 1.19
Treatment outcomes in REM sleep behavior disorder. Sleep Med (2013) 1.19
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol (2004) 1.14
Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med (1996) 1.14
Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry (2002) 1.11
Restless legs syndrome associated with major diseases: A systematic review and new concept. Neurology (2016) 1.11
Sleep disorders in Parkinson's disease. J Neurol (1998) 1.09
The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol (2015) 1.08
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.08
Periodic leg movements during sleep and wakefulness in narcolepsy. J Sleep Res (2007) 1.07
The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J Clin Psychiatry (2000) 1.04
Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. J Neurosurg (2006) 1.04
Melatonin for sleep disturbances in Parkinson's disease. Sleep Med (2005) 1.04
Circadian and sleep disorders in Parkinson's disease. Exp Neurol (2012) 1.03
Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology (2006) 1.02
Nightmares: from anxiety symptom to sleep disorder. Sleep Med Rev (2005) 1.00
Sleep disturbances in Parkinson's disease: the contribution of dopamine in REM sleep regulation. Sleep Med Rev (2013) 1.00
Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. J Sleep Res (2011) 0.99
Are periodic leg movements during sleep (PLMS) responsible for sleep disruption in insomnia patients? Eur J Neurol (2000) 0.98
Effects of levodopa on pulmonary function in Parkinson's disease. Chest (2001) 0.98
Sleep-related respiratory and haemodynamic changes in Shy-Drager syndrome: a case report. J Neurol (1985) 0.97
Daytime sleepiness and alertness in patients with Parkinson disease. Sleep (2004) 0.96
Mono-amine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol (1970) 0.96
Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS. Parkinsonism Relat Disord (2009) 0.96
Excessive daytime sleepiness and unintended sleep in Parkinson's disease. Curr Neurol Neurosci Rep (2006) 0.94
Sleep and Parkinson's disease: a review of case-control polysomnography studies. Mov Disord (2012) 0.94
Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry (2002) 0.93
Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Med (2004) 0.93
Melatonin in Alzheimer's disease. Int J Mol Sci (2013) 0.92
Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease. Mov Disord (2011) 0.92
Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord (2002) 0.92
Decreased phasic EMG activity during rapid eye movement sleep in treatment-naïve Parkinson's disease: effects of treatment with levodopa and progression of illness. Mov Disord (2002) 0.91
An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder. J Clin Sleep Med (2016) 0.91
Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat Disord (2011) 0.91
Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Arch Neurol (2008) 0.90
Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. Ann Pharmacother (2012) 0.89
Sleepwalking in patients with Parkinson disease. Arch Neurol (2007) 0.89
Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies. Sleep Med Rev (2010) 0.89
Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding. J Neurol (2003) 0.89
L-dopa-induced respiratory disturbance in Parkinson's disease suppressed by tiapride. Neurology (1985) 0.89
Periodic leg movements are associated with reduced sleep quality in older men: the MrOS Sleep Study. J Clin Sleep Med (2013) 0.89